Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$671,927
+$366,425 QoQ
Shares Held
14,016
+68.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#632
of 1,348 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF HAWAII holds $33,752,794 across 11 Drug Manufacturers - General names. NVO ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
36,030 | $9,150,539 | |
| 2 | LLY |
ELI LILLY & Co
|
5,999 | $7,195,380 | |
| 3 | ABBV |
AbbVie Inc.
|
27,871 | $7,013,457 | |
| 4 | MRK |
Merck & Co., Inc.
|
38,915 | $5,000,577 | |
| 5 | BIIB |
Biogen Inc.
|
6,780 | $1,464,886 | |
| 6 | PFE |
Pfizer Inc
|
41,818 | $1,006,977 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,468 | $718,406 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
14,016 | $671,927 |
All Filings in NVO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $671,927 | 14,016 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $305,502 | 8,313 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $424,593 | 8,345 | Shares | Defined | 2026-03-03 | |
| 2025-09-30 | $256,252 | 4,618 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||